Status:

COMPLETED

Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up

Lead Sponsor:

Istituto Auxologico Italiano

Conditions:

COVID-19

Cardiovascular Risk Factor

Eligibility:

All Genders

18+ years

Brief Summary

Northern Italy, and particularly Lombardy, is one of the regions of the world mostly affected by COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To investig...

Detailed Description

Background COVID-19 has shown a lower case-fatality rate compared to other major viral outbreaks in contemporary history, including severe acute respiratory syndrome (SARS) of 2002-2003. However, the...

Eligibility Criteria

Inclusion

  • Positivity to the test for COVID-19 and / or chest Xray or CT positive for interstitial pneumonia compatible with infection with this virus, regardless of the severity of the infection and the need or not for hospitalization
  • Informed consent freely granted also verbally

Exclusion

  • Failure to satisfy the inclusion criteria

Key Trial Info

Start Date :

April 8 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 10 2021

Estimated Enrollment :

4356 Patients enrolled

Trial Details

Trial ID

NCT04371289

Start Date

April 8 2020

End Date

September 10 2021

Last Update

February 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istituto Auxologico Italiano

Milan, Italy